Does NIVOLUMAB Cause Lymphadenopathy? 293 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 293 reports of Lymphadenopathy have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
293
Reports of Lymphadenopathy with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
32
Deaths
125
Hospitalizations
How Dangerous Is Lymphadenopathy From NIVOLUMAB?
Of the 293 reports, 32 (10.9%) resulted in death, 125 (42.7%) required hospitalization, and 16 (5.5%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 293 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which NIVOLUMAB Alternatives Have Lower Lymphadenopathy Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE